PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
6.10%
Net income growth above 1.5x MCHP's 2.37%. David Dodd would see a clear bottom-line advantage if it is backed by stable operations.
-1.69%
Negative yoy D&A while MCHP is 16.12%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
-5800.00%
Negative yoy deferred tax while MCHP stands at 6.08%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
7.69%
SBC growth well above MCHP's 14.65%. Michael Burry would flag major dilution risk vs. competitor’s approach.
46.99%
Less working capital growth vs. MCHP's 658.25%, indicating potentially more efficient day-to-day cash usage. David Dodd would confirm no negative impact on revenue.
74.03%
AR growth well above MCHP's 120.99%. Michael Burry would fear inflated sales or less stringent credit controls vs. competitor.
31.67%
Some inventory rise while MCHP is negative at -71.75%. John Neff would see competitor possibly benefiting from leaner stock if demand remains.
68.52%
A yoy AP increase while MCHP is negative at -158.26%. John Neff would see competitor possibly improving relationships or liquidity more rapidly.
-12.90%
Both reduce yoy usage, with MCHP at -46.09%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
471.43%
Some yoy increase while MCHP is negative at -20.24%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
34.65%
Operating cash flow growth above 1.5x MCHP's 15.84%. David Dodd would confirm superior cost control or stronger revenue-to-cash conversion.
-1.63%
Negative yoy CapEx while MCHP is 13.22%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
No Data
No Data available this quarter, please select a different quarter.
-174.33%
Both yoy lines negative, with MCHP at -3.24%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
39.84%
We have some liquidation growth while MCHP is negative at -29.69%. John Neff notes a short-term liquidity advantage if competitor is holding or restricted.
-11600.00%
We reduce yoy other investing while MCHP is 9.81%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-210.13%
We reduce yoy invests while MCHP stands at 9.05%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
No Data
No Data available this quarter, please select a different quarter.
-79.27%
Both yoy lines negative, with MCHP at -100.00%. Martin Whitman suspects an environment or preference for internal financing over new equity in the niche.
2.39%
Buyback growth of 2.39% while MCHP is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.